What are the causes and treatment options for nephrosis in a 38-year-old adult?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Nephrosis in a 38-Year-Old Adult

The most common causes of nephrosis in a 38-year-old adult are primary focal segmental glomerulosclerosis (FSGS) and membranous nephropathy for idiopathic causes, while diabetes mellitus is the most common secondary cause.

Primary (Idiopathic) Causes

Most Common Primary Causes

  • Focal Segmental Glomerulosclerosis (FSGS)

    • Most common cause of acquired nephrotic syndrome leading to end-stage renal disease in adults 1
    • Characterized by scarring in parts of the glomeruli
    • Can be steroid-resistant in >50% of adult patients 2
  • Membranous Nephropathy

    • Associated with anti-phospholipase A2 receptor (PLA2R) antibodies 1
    • Higher risk of thromboembolic complications 2
    • Often responds to calcineurin inhibitors or rituximab 2
  • Minimal Change Disease (MCD)

    • More common in children but can occur in adults
    • Characterized by massive proteinuria with diffuse fusion of podocytes without visible immune deposits 1
    • Generally responds well to corticosteroids 2

Secondary Causes

Most Common Secondary Causes

  • Diabetes Mellitus

    • Most common secondary cause of nephrotic syndrome in adults 1, 3
    • Presents with characteristic diabetic nephropathy
  • Systemic Lupus Erythematosus

    • Can present with lupus nephritis
    • May require immunosuppressive therapy based on biopsy classification 2
  • Infections

    • HIV, hepatitis B, hepatitis C, syphilis 1
    • Screening for these infections is recommended in appropriate clinical contexts 2
  • Medications

    • NSAIDs, gold, penicillamine, certain antibiotics
    • Suspension of causative medications may be necessary 1
  • Amyloidosis

    • Deposition of abnormal protein in kidney tissue
    • May be primary or secondary to chronic inflammatory conditions
  • Malignancies

    • Particularly hematologic malignancies (lymphoma, leukemia)
    • Solid tumors can also cause paraneoplastic glomerular disease

Diagnostic Approach

  1. Initial Laboratory Evaluation

    • Quantification of proteinuria (>3.5 g/day defines nephrotic range)
    • Serum albumin (<3.0 g/dL in nephrotic syndrome)
    • Lipid profile (typically elevated in nephrotic syndrome)
    • Complete blood count
    • Serum creatinine and estimated GFR
    • Serological tests (ANA, complement levels, hepatitis panels, HIV) 1
  2. Renal Biopsy

    • Necessary for definitive diagnosis in adults with unexplained proteinuria >3.0 g/g creatinine 1
    • Helps distinguish between primary and secondary causes
    • KDIGO guidelines recommend biopsy for accurate diagnosis and treatment planning 2
  3. Genetic Testing

    • Consider in cases of:
      • Familial renal disease
      • Steroid-resistant FSGS
      • Early-onset disease
      • 11-24% of adults with steroid-resistant FSGS have causative genetic variants 1

Treatment Considerations

Treatment depends on the underlying cause:

  1. Primary Glomerular Diseases

    • FSGS: High-dose corticosteroids (prednisone 1 mg/kg/day) for 4-16 weeks 2
    • Membranous Nephropathy: Rituximab, cyclophosphamide with oral prednisolone, or calcineurin inhibitors 1
    • Minimal Change Disease: Prednisone 1 mg/kg/day (maximum 80 mg) 2
  2. Secondary Causes

    • Treatment of underlying condition (e.g., antiretroviral therapy for HIV, glycemic control for diabetes)
    • Immunosuppression generally not recommended for secondary FSGS 1
  3. Supportive Care

    • RAS inhibition for proteinuria and blood pressure control 2
    • Anticoagulation for high-risk patients, especially with membranous nephropathy 2
    • Lipid management with statins 2
    • Sodium restriction and diuretics for edema management 1

Complications to Monitor

  • Venous thromboembolism (particularly in membranous nephropathy)
  • Infections due to urinary loss of immunoglobulins
  • Acute kidney injury
  • Cardiovascular complications from dyslipidemia and hypertension

Proper identification of the underlying cause of nephrosis is crucial for appropriate management and improving outcomes in a 38-year-old patient.

References

Guideline

Nephritic and Nephrotic Syndromes Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Nephrotic Syndrome.

Primary care, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.